amifampridine has been researched along with Memory Disorders in 2 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schweizer, T | 1 |
| Birthelmer, A | 1 |
| Lazaris, A | 1 |
| Cassel, JC | 1 |
| Jackisch, R | 1 |
| Beninger, RJ | 1 |
| Wirsching, BA | 1 |
| Mallet, PE | 1 |
| Jhamandas, K | 1 |
| Boegman, RJ | 1 |
2 other studies available for amifampridine and Memory Disorders
| Article | Year |
|---|---|
3,4-DAP-evoked transmitter release in hippocampal slices of aged rats with impaired memory.
Topics: 4-Aminopyridine; Acetylcholine; Aging; Amifampridine; Animals; Female; Hippocampus; Maze Learning; M | 2003 |
Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats.
Topics: 4-Aminopyridine; Amifampridine; Animals; Cerebral Cortex; Choline O-Acetyltransferase; Dose-Response | 1995 |